UBS AG Logo
Login | Preferences | Contact |engita
UBS Fund Gate - Luxembourg
   
Home
News
Products
Compare products
Virtual portfolios
E-mail subscription
General information
 
 
Search for products
Overview
Search by criteria
Product information
Print "Daily Fact Sheet"Print version as PDF file format
UBS products  ›  Product information
UBS (Lux) Equity Fund - China Opportunity (USD) P-acc
Investments in Chinese equities
ISIN no.:  LU0067412154
PDF
PDF
PDF
Overview  
Category profile
UBS Opportunity Equity Funds are actively managed funds which exploit three different earnings sources: large caps / blue chips, small/mid caps and a flexible liquidity component. Portfolio managers are able to allocate the funds' assets in line with the best return potential. These funds capture our best recommendations from research in a concentrated way, achieving superior returns primarily through active stock selection, tactical active cash allocation and strategic small and mid cap allocation.

Fund description
Very actively managed equity fund based on a concentrated equity portfolio investing in selected Chinese companies
The manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.
Diversified across sectors offering broad coverage of the Chinese market

Key benefits
Easy access to investment opportunities provided by a rapidly growing Chinese economy. Investors gain access to all classes of shares providing China equity exposure: A, B and H shares as well as Red Chips
Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.
Investors benefit from UBS being one of the few asset managers with a truly global investment platform
The experienced portfolio management team can leverage local investment expertise in the Chinese market via our joint venture UBS SDIC in China

Risks
UBS Opportunity Equity Funds invest in equities and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. As these UBS Funds pursue an active management style, each Fund's performance can deviate substantially from that of its reference index. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).

Product features
Product type
Open end
Product category
UBS Equity Funds
UBS Opportunity Equity Funds
Product domicile
Luxembourg
Portfolio management
UBS Asset Management, Hongkong
Fund management
UBS Fund Management (Luxembourg) S.A.
Custodian bank
UBS Europe SE, Luxembourg Branch
Day of inception
November 15, 1996 1)
Currency of account
USD
Close of financial year
November 30
Issue / redemption
daily
Distribution
Reinvestment
Management fee
1.87% p.a.
Total expense ratio (TER)
2.41% p.a.
Swing pricing
yes
Reference Index / Benchmark
MSCI China (net div. reinv.)
1)  Repositioned to current strategy on 16 July 2010. Old sub-fund name was UBS (Lux) Equity Fund - Hong Kong

Current data
Net asset value
USD1,300.77
20/10/2017
High - last 12 months
USD1,313.11
17/10/2017
Low - last 12 months
USD832.52
23/12/2016
Assets of the unit class in mn
USD2,076.71
20/10/2017
Total product assets in mn
USD2,755.26
20/10/2017

Statistical data
 
2 years
5 years
 
Total risk reference index / benchmark
17.99%
18.66%
29/09/2017
Sharpe Ratio
1.64
1.08
29/09/2017
Risk Free Rate
0.77%
0.44%
29/09/2017

Symbols
ISIN no.
LU0067412154
Bloomberg Ticker
SBCEHKI LX
Reuters Id
UBSFUNDS10
Telekurs Id
EPHK

 
Performance chart (USD-based, as of October 20, 2017)
Indexed, Month-end values
Performance chart (USD-based, as of October 20, 2017)


Performance (in %, as of October 20, 2017)
in %
1
year
3
years
5
years
ø p.a.
5 years
USD
41.07
67.68
149.79
20.09
EUR
30.77
81.81
176.16
22.53
These figures refer to the past. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.
Peer group (as of September 30, 2017)
 
1
year
3
years
5
years
Fund (USD, in%)
34.26
60.48
150.09
Ø peer group (in %) 1)
25.36
38.01
64.93
Quartile ranking 2)
1
1
1
1)  Average performance Lipper Global Classification (LGC)
2)  Quartile 1,2,3,4; e.g.: 1= fund is part of the best 25% of all funds of the peer group
Peer group information. Peer group category used: LGC Equity China, based on mutual funds in the "MSCI Europe Developed Markets Universe" ex institutional and insurance funds, ETF's and Pension Trusts. Source and calculation: Lipper, a Thomson Reuters Company

By sector (in %, as of September 29, 2017)
Chart

By the 10 largest equity positions (in %, as of September 29, 2017)
TENCENT HOLDINGS LTD
9.63
TAL EDUCATION GROUP ADR
9.61
ALIBABA GROUP HOLDING LTD
9.24
PING AN INSURANCE H CNY1
7.86
BAIDU.COM ADS
4.31
SHENZHEN INTL HOLDINGS
4.08
NETEASE INC-ADR
2.97
CSPC PHARMACEUTICAL GROUP LT
2.13
LIVZON PHARMACEUTICAL GROU-H
2.05
FAR EAST HORIZON LTD
1.99
Up to 31 January 2006, MSCI benchmark with gross dividends reinvested, from 1 February 2006 with net dividends reinvested.
For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS Fund Services (Luxembourg) S.A., P.O. Box 91, L-2010 Luxembourg or from UBS Europe SE, Luxembourg Branch, P.O. Box 2, L-2010 Luxembourg. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management
Source for all data and charts (if not indicated otherwise): UBS Asset Management
No responsibility is taken for the correctness of the information provided above.

Important legal information - please read the disclaimer before proceeding.
Products and services in these web pages may not be available for residents of certain nations.
Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2017. All rights reserved.
Privacy Policy